Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter

Sun Pharma Advanced Research Company Ltd on Monday said its net loss widened to Rs 81.99 crore in the fourth quarter ended March 2023, impacted by higher expenses.

Sun Pharma Advanced Research loss widens to Rs 81.99 cr in March quarter

There has been a significant increase in clinical trial expenses, product development expenses, and professional charges during the last quarter of financial year 2022-23.

Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore

Sun Pharma Advanced Research Company may incur expenses in connection with incident; India was the second most attacked country for ransomware in the APAC-Japan region in 2022

Sun Pharma may incur revenue loss for ransomware incident on March 2

Sun Pharma Advanced Research Company Limited (SPARC) informed that an IT security incident occurred earlier this month and the necessary steps to gauge, contain and mitigate the impact of the incident as well as to safeguard the integrity of our systems infrastructure and data have been promptly ini…

SPARC reports IT security incident, ransomware group claims responsibility

Sun Pharma Advanced Research Company Ltd notched up volume of 87.7 lakh shares by 14:14 IST on NSE, a 17.26 fold spurt over two-week average daily volume of 5.08 lakh shares

Volumes spurt at Sun Pharma Advanced Research Company Ltd counter

G R Infraprojects Ltd, Valiant Organics Ltd, Star Cement Ltd and Aegis Logistics Ltd are among the other gainers in the BSE’s ‘A’ group today, 23 March 2023.

Sun Pharma Advanced Research Company Ltd leads gainers in ‘A’ group

Olectra Greentech Ltd, Sun Pharma Advanced Research Company Ltd, Brightcom Group Ltd and Network 18 Media & Investments Ltd are among the other losers in the BSE’s ‘A’ group today, 15 March 2023.

Swan Energy Ltd leads losers in ‘A’ group

Sun Pharma Advanced Research Company reported a net profit of Rs 10.15 crore in Q3 FY23 as against a net loss of Rs 15.84 crore in Q3 FY22.

SPARC records PAT of Rs 10 crore in Q3; turns profitable after several quarters

Sun Pharma Advanced Research Company (SPARC) is a clinical-stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 following its demerger from Sun Pharma, a global leader in …

Rekha Jhunjhunwala picks 2% stake in smallcap pharma stock

Jyothy Labs Ltd, Wockhardt Ltd, Sun Pharma Advanced Research Company Ltd and Ajanta Pharma Ltd are among the other gainers in the BSE’s ‘A’ group today, 22 December 2022.

Morepen Laboratories Ltd leads gainers in ‘A’ group

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Profitability and efficiency haven't been upto the mark

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).